Insider Transactions in Q4 2021 at Agios Pharmaceuticals, Inc. (AGIO)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2021
|
Jonathan Biller Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,823
-10.97%
|
$63,805
$35.88 P/Share
|
|
Dec 03
2021
|
Jonathan Biller Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,753
+25.71%
|
-
|
|
Dec 02
2021
|
Sarah Gheuens Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
248
-5.77%
|
$8,680
$35.0 P/Share
|
|
Dec 02
2021
|
Sarah Gheuens Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
834
+16.26%
|
-
|